Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Biotech's New Blockbusters -- Oh, Really?
- Biotech's New Blockbusters -- Oh, Really?20 to 30 Blockbusters of Biotech Exist NowInnovation in Pharmacology?Beginning in the 1970, biopharmaceuticals were being researched for conceptual production in those places once called academic institutions. The first biopharmaceutical ever was a synthetic insulin called Humulin made by Genetech in 1982. Later...
- Discussion threads 2008-07-10
- Sanguine Meets with FDA To Define PHER-O2 Regulatory Path
- PASADENA, Calif. -- Second graph, first sentence of release dated Dec. 5, 2006 should read: PIRIBO, a well known BioPharma Industry analyst, reported that the annual organ and tissue transplantation market in the U.S. was estimated at $11.7 billion in 2005 and is expected to rise at an average annual...
- Research articles 2006-12-06
Additional Resources
- ONDINE BIOPHARMA CORPORATION - Ondine Biopharma Corporation Receives ISO Certification.
- Ondine Biopharma Corporation Receives ISO 13485 Certification VANCOUVER, Oct. 4 /CNW/ - Ondine Biopharma Corporation (TSX: OBP; AIM: OBP) today announced that it has achieved ISO 13485 certification, a critical step to the...
- Research articles 2005-10-04
- ONDINE BIOPHARMA CORPORATION - Product Launch.
- Ondine Biopharma Launches PERIOWAVETM - Photodynamic Disinfection product released at Pacific Dental Conference - VANCOUVER, March 8 /CNW/ - Ondine Biopharma...
- Research articles 2006-03-08
- Ondine Biopharma, Henry Schein enter into agreement.
- Ondine Biopharma and Henry Schein enter into strategic distribution agreement VANCOUVER, Dec. 13 /CNW/ - Ondine Biopharma Corporation (TSX-V:OBP, AIM: OBP) ("Ondine") announced today that a strategic agreement in...
- Research articles 2004-12-13
- ONDINE BIOPHARMA CORPORATION - Directorate Change.
- Ondine Biopharma Appoints Michael Richard Crane to its Board of Directors VANCOUVER, May 1 /CNW/ - Ondine Biopharma Corporation ("the Company", TSX: OBP; AIM: OBP) today announced the appointment...
- Research articles 2006-05-02
- PDL BioPharma Q4 2005 Earnings Conference Call Transcript (PDLI)
- Earnings Call Excerpt PDL BioPharma Q4 2005 Results Conference Call PDLI February 27, 2006 Executives Ami Knoefler, Sr. Director Corporate Investor Relations Mark McDade, Chief Executive Officer Steven Benner, Chief Medical Officer Analysts Bret Holley, CIBC World Markets Eric Hoffman,...
- Earnings calls 2006-02-28
- AVI Biopharma Q3 2005 Earnings Conference Call Transcript (AVII)
- Earnings Call Excerpt Third Quarter 2005 Financial Results Conference Call Transcript Moderator: Denis Burger November 4, 2005 8:00 a.m. Pacific Time Operator: Welcome to the AVI BioPharma 2005 Third Quarter Financial Results conference call. At this time all participants are in a...
- Earnings calls 2005-11-04
- SAFE-BioPharma Creates First Electronic Trusted Identity Link between Pharma and Healthcare Industries and US Government Agencies
- FT. LEE, N.J. -- SAFE-BioPharma Association today announced activation of the first electronic bridge enabling trusted transactions between many of the world's largest pharmaceutical companies and key US government agencies, including the FDA, Health and Human Services, Department of Defense, Homeland Security and the US Patent and Trademark Office. SAFE-BioPharma...
- Research articles 2008-04-15
- Array BioPharma to Present at the Banc of America Securities Healthcare Conference
- BOULDER, Colo. -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Banc of America Securities Healthcare Conference on May 13 in Las Vegas. The public is welcome to participate in the conference through a webcast on the Array BioPharma...
- Research articles 2008-05-08
- Array BioPharma to Present at the 25th Annual JPMorgan Healthcare Conference
- BOULDER, Colo. -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the 25th Annual JPMorgan Healthcare Conference on January 8 in San Francisco. The public is welcome to participate in the conference through an audio webcast on the Array BioPharma...
- Research articles 2006-12-22
- Array BioPharma to Present at the 19th Annual Piper Jaffray Health Care Conference
- BOULDER, Colo. -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the 19th Annual Piper Jaffray Health Care Conference on November 28 in New York City. The public is welcome to participate in the conference through a webcast on the...
- Research articles 2007-11-20
- Array BioPharma to Present at the 26th Annual JPMorgan Healthcare Conference
- BOULDER, Colo. -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the 26th Annual JPMorgan Healthcare Conference on January 7 in San Francisco. The public is welcome to participate in the conference through an audio webcast on the Array BioPharma...
- Research articles 2008-01-03
- Helix Biopharma Corp. Completes Common Share Private Placement
- VANCOUVER, British Columbia--BUSINESS WIRE--May 31, 1996--HELIX BIOPHARMA (VSE:HBP)TSE ListingHelix BioPharma Corp. ("Helix BioPharma") is pleased to announce that the Toronto Stock Exchange has approved the listing of the Company's common shares on the Exchange. Trading will commence at the opening on Monday, June 3, 1996. Private PlacementFurther to the Company's...
- Research articles 1996-05-31
- Helix BioPharma Corp. and Pence Announce Third Research and Development Partnership
- RICHMOND, British Columbia--BUSINESS WIRE--Aug. 5, 1997--Helix BioPharma Corp (TSE,VSE:HBP.) Helix BioPharma Corp.'s (TSE/VSE:HBP) strategy of developing alliances with Canadian institutions involved in leading-edge scientific research and technology has once again resulted in Helix achieving a competitive advantage. Helix BioPharma Corp. and The Protein Engineering Network of Centres of Excellence...
- Research articles 1997-08-05
- Swedish Biopharma at Large - What Next?
- Sweden has a rapidly expanding biotechnology sector that presently ranks fourth in Europe after Germany, UK, and France. The great majority of pipeline projects are in pre-clinical research. The Swedish Biopharma industry has more than doubled in the last six years, growing from 25 companies in 1996 to the current...
- White papers 2002-09-01
- Good Governance Gives Good Value: Rising to the Productivity Challenge in Biopharma R&D
- The paper outlines the productivity challenge in biopharma R&D. Good governance is easy in concept but difficult in practice. It is especially difficult in biopharma R&D because of the large number of variables and uncertainties involved. To improve governance, companies should focus on improving decision authority, decision criteria, decision communication,...
- White papers 2004-07-01
- Pfizer's George Rathbun Named Chief Technology Officer, SAFE-BioPharma Association
- George Rathbun, Director of Architecture in Pfizer's Global Research and Development Informatics organization, has been named Chief Technology Officer of SAFE-BioPharma Association, it was announced today. Pfizer has seconded Mr. Rathbun to SAFE-BioPharma, the pharmaceutical industry sponsored organization developing and managing a secure digital signature standard for use globally throughout...
- Research articles 2005-11-17
- Hemispherx Biopharma's Alferon N Highlighted as Potential New Therapy for Avian Influenza on CNBC's 'Closing Bell'; 'Battling the Bird Flu' Segment Features Microcap Company as Contender in the Avian Flu Drug Manufacturing Race
- PHILADELPHIA -- Hemispherx Biopharma, Inc. (AMEX:HEB) was highlighted on CNBC's "Closing Bell" program yesterday in a segment on Avian Flu. Pharmaceuticals reporter Mike Huckman reported that the World Health Organization has predicted that the Avian Flu threatens to spread around the world and infect millions of people. Huckman focused on...
- Research articles 2005-02-24
- Array BioPharma to Present at the UBS Global Life Sciences Conference
- BOULDER, Colo. -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the UBS Global Life Sciences Conference on September 24 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma...
- Research articles 2007-09-17
- << Previous
- page 1 of 1
- Next >>
